Publication | Open Access

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy

Neuro-oncologySurgical OncologyRadiation TherapyMelanoma Brain MetastasesMedicineMelanomaBraf InhibitorClinical OutcomesCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences